HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 

Alexion Pharmaceuticals NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Thu, 17 Jan 2019 17:41:03 GMTGoogle News
Recent Fundamentals: – Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)  Nyse NewsToday

The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or ...

Nyse NewsToday
Alexion Comes Roaring Back To Protect Its Key Drug Program  Seeking Alpha

Alexion announced it had received FDA approval of Ultomiris for treating patients with paroxysmal nocturnal hemoglobinuria or PNH. The FDA approval of ...

Seeking Alpha
Alexion Pharmaceuticals Enters Oversold Territory  Zacks.com

Alexion Pharmaceuticals has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Zacks.com
EOG Resources, Inc. (EOG) and Alexion Pharmaceuticals, Inc. (ALXN) Rally In Jeopardy?  Financial Mercury

Looking at top Wall Street opinions, EOG Resources, Inc. (NYSE: EOG) has recently made its way into the research list of RBC Capital Mkts – signaling that their ...

Financial Mercury
The luring statistics of these names: Alexion Pharmaceuticals, Inc. (ALXN), Principal Financial Group, Inc. (PFG)  FinBulletin

As observed over the last 9-day period, Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares have generated an observed Historic Volatility of 35.83%.

FinBulletin
Investment Research Analysts Opinion: Alexion Pharmaceuticals, Inc. (ALXN), Banco Santander (Brasil) S.A. (BSBR)  Analyst Journal

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) tinted loss of -0.03% (-0.03 points) to US$111.7. The volume of 2.13 Million shares climbed up over an trading ...

Analyst Journal
Form 8-K ALEXION PHARMACEUTICALS, For: Dec 21  StreetInsider.com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT PURSUANT TO SECTION 13 OR ...

StreetInsider.com
Alexion Pharmaceuticals, Inc. (ALXN)- Prime Game Changers Stocks for the Day  NASDAQ Times

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) traded under umbrella of Healthcare sector, shares jumped up 3.86% to trade at $111.73 in the last beat.

NASDAQ Times
Trending Stocks In Review :: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)  Global Export Lines

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Global Export Lines
Stifel Remains Sidelined on Alexion Pharma (ALXN) Following FDA Approval of Ultomiris  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Stifel analyst, Paul Matteis, reiterated a Hold ...

StreetInsider.com
Wall Street Analysts Give Investors What They Want about Alexion Pharmaceuticals (ALXN)  Voice Of Analysts

Alexion Pharmaceuticals (ALXN) stock managed performance 2.87% over the last week and switched with performance of -0.62% throughout past one month ...

Voice Of Analysts
Factors That Affect Stock: Alexion Pharmaceuticals (ALXN)  Stock News Stop

As a general matter investors should not rely solely on an analyst's recommendation when deciding whether to buy, sell or hold a stock. It is suggested that a ...

Stock News Stop
U.S. FDA approves Alexion Pharma's rare blood disorder drug  Nasdaq

By Manas Mishra. Dec 21 (Reuters) - The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc's rare blood disorder drug ...

Nasdaq
Alexion Pharma Announces FDA Approval Of ULTOMIRIS  Markets Insider

(RTTNews) - Alexion Pharmaceuticals, Inc. (ALXN), on Friday, announced the U.S. FDA approved ULTOMIRIS for the treatment of adult patients with paroxysmal ...

Markets Insider
Current Alteration:: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)  Nyse News Updates

Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price ...

Nyse News Updates
Alexion Pharmaceuticals (ALXN) Stock with Considerable Review with Volatility and volume  Investing News Update

Alexion Pharmaceuticals (ALXN) stock price rose 3.86% with the closing value of $111.73 during Tuesday trading session. Alexion Pharmaceuticals traded ...

Investing News Update
Options Are Looking Quite Attractive: Halliburton Company (HAL), Alexion Pharmaceuticals, Inc. (ALXN)  NMSU Nеws

Beaty Anne L., Senior VP, Finance, sold 1,588 shares of the Halliburton Company (NYSE:HAL) in an exchange that happened on January 9th. The stock was ...

NMSU Nеws
Will Shareholder Love To Invest in This Stock? – Alexion Pharmaceuticals (NASDAQ: ALXN)  Seekingfin

Alexion Pharmaceuticals (NASDAQ: ALXN) stock experienced a change of -0.03% in final minutes of Wednesday's trading session. The stock closed the last ...

Seekingfin
Alexion Pharmaceuticals, Inc. (ALXN) PI Quant Signal Hits 1.021018  Hawthorn Caller

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Alexion Pharmaceuticals, Inc. (ALXN) for last month.

Hawthorn Caller
Alexion Pharmaceuticals (NASDAQ:ALXN) Gets Approval From FDA For Ultomiris' Treatment Of Paroxysmal Nocturnal Hemoglobinuria  FDA Headlines

Jan 8, 2019 | Business. Alexion Pharmaceuticals (NASDAQ:ALXN) Gets Approval From FDA For Ultomiris' Treatment Of. Alexion Pharmaceuticals ...

FDA Headlines
Quant Signal & Rank Update For Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) as ROA Hits 0.011185  Bay City Observer

Taking a look at some key metrics and ratios for Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN), we note that the ROA or Return on Assets stands at.

Bay City Observer
Alexion Pharmaceuticals (ALXN) predicted to achieve EPS growth of 23.50% for this year  Wallstreet Investorplace

Growth in earnings per share is everything. The expected future growth in earnings per share (EPS) is an incredibly important factor .in identifying an ...

Wallstreet Investorplace
Jefferies Group LLC Purchase 8138 Shares of Alexion Pharmaceuticals, Inc. (ALXN)  BharataPress

Jefferies Group LLC increased its position in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 124.6% during the third quarter, according to its most ...

BharataPress
Gulf International Bank UK Ltd Sells 21,652 Shares of Alexion Pharmaceuticals, Inc. (ALXN)  Fairfield Current

Gulf International Bank UK Ltd lessened its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 28.3% during the fourth quarter, according to its most ...

Fairfield Current
Stock Analysis Under a Powerful Visual Trend-Spotting Tool – Alexion Pharmaceuticals (NASDAQ: ALXN)  Alpha Beta Stock

Alexion Pharmaceuticals (NASDAQ: ALXN) stock encountered a rapid change of -0.03% in the last hour of Wednesday's trading session. The stock settled the ...

Alpha Beta Stock
Peeling The Layers Back on Valuation For Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN)  Felton News

Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) boasts a Price to Book ratio of 2.718364. This ratio is calculated by dividing the current share price by the.

Felton News
Alexion Pharmaceuticals Inc. (ALXN) Dips 3.23% for December 18  Equities.com

Alexion Pharmaceuticals Inc. is a Alexion Pharmaceuticals specializes in developing and marketing drugs for life-threatening medical conditions.

Equities.com
What is mean by High Beta Stock?: Alexion Pharmaceuticals (ALXN)  Wallstreet Investorplace

Alexion Pharmaceuticals (ALXN) closed the Friday at final price of $111.13 after traded 1339548 shares. The average volume was noted at 1733.08K shares ...

Wallstreet Investorplace
Alexion Pharmaceuticals (ALXN) Rating Reiterated by Raymond James  Fairfield Current

Alexion Pharmaceuticals (NASDAQ:ALXN)'s stock had its “buy” rating reiterated by Raymond James in a research note issued on Friday, December 21st. ALXN ...

Fairfield Current
Stock-research Ratings: Albemarle Corporation (ALB), Alexion Pharmaceuticals, Inc. (ALXN)  Analyst Journal

Albemarle Corporation (NYSE:ALB) tinted gains of +0.18% (+0.14 points) to US$77.41. The volume of 1.53 Million shares climbed up over an trading activity of ...

Analyst Journal
Alexion Pharmaceuticals, Inc. (ALXN) do stock crosses SMA-20  Nasdaq Click

Alexion Pharmaceuticals, Inc. (ALXN) stock figure shut its day with gain 0.18% and conclude at the price of $111.13, its 52 week- top value and changed 20.06% ...

Nasdaq Click
Alexion Pharmaceuticals (ALXN) stock accomplished recent price of $110.48  News Leading

Investors tracking shares of Alexion Pharmaceuticals (ALXN) may be focusing on where the stock is trading relative to its 52-week high and low. At the time of ...

News Leading
Alexion Pharmaceuticals (ALXN) Rating Repeats by Credit Suisse Group  BharataPress

Alexion Pharmaceuticals (NASDAQ:ALXN)'s stock had its “buy” rating reiterated by research analysts at Credit Suisse Group in a note issued to investors on ...

BharataPress
Analyst Stock Ratings: Alexion Pharmaceuticals, Inc. (ALXN)), Lululemon Athletica Inc. (LULU))  Analyst Journal

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)) tinted gains of +4.18% (+3.93 points) to US$97.87. The volume of 1.93 Million shares climbed up over an ...

Analyst Journal
Time For Sell-Side To Throw In Towel? – Alexion Pharmaceuticals, Inc. (ALXN), Edison International (EIX)  Post Analyst

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) notched a -6.51% intraday decline moving at $94.63. When the opening bell rang, the price was $101.19.

Post Analyst
Nordea Investment Management AB Reduces Position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)  Fairfield Current

Nordea Investment Management AB decreased its position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 88.6% during the third quarter, according to the ...

Fairfield Current
There are countless reason to get interested in these stocks: Alexion Pharmaceuticals, Inc. (ALXN), Immunomedics, Inc. (IMMU)  NMSU Nеws

Franchini Indrani Lall, EVP, Chief Compliance Officer, sold 2,605 shares of the Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in an exchange that happened ...

NMSU Nеws
Alexion Pharmaceuticals, Inc. (ALXN) registers a price change of 0.88% while Ocular Therapeutix, Inc. (OCUL) finishes with a flow of -3.61%  Stocks Gallery

Alexion Pharmaceuticals, Inc. (ALXN) Stock Price Movement: In recent trading day Alexion Pharmaceuticals, Inc. (ALXN) stock showed the move of 0.88% with ...

Stocks Gallery
What’s Happening To These Stocks? – McDermott International, Inc. (MDR), Alexion Pharmaceuticals, Inc. (ALXN)  Post Analyst

The opening price for McDermott International, Inc. (NYSE:MDR) was $8.05 and the volume amounted to 2374119 shares which compares with the average ...

Post Analyst
Alexion's Second C5 Complement Inhibitor Requires Less Frequent Dosing, Carries New Patents  The Center for Biosimilars

Eculizumab must be administered every 2 weeks, versus every 8 weeks for the newly approved ravulizumab. Another possible advantage for Alexion is that the ...

The Center for Biosimilars
The Big Impact Of Technical Data: Zions Bancorporation, National Association (ZION), Alexion Pharmaceuticals, Inc. (ALXN)  NMSU Nеws

With Zions Bancorporation, National Association (NASDAQ:ZION) price's latest movement, it is now -25.68% away from its 1-year high and 15.52% higher than ...

NMSU Nеws
Will Positive Phase III Data For Roche's Anti IL-6 Antibody Spell Trouble For Alexion's C5 Inhibitor In NMOSD?  Seeking Alpha

NMOSD is a rare and severe autoimmune disease with little to no viable treatment options for patients. Alexion and Roche are leveraging two unique ...

Seeking Alpha
A Roadblock Ahead? – Canadian National Railway Company (CNI), Alexion Pharmaceuticals, Inc. (ALXN)  Post Analyst

Jan 09 was a weak volume day for Canadian National Railway Company (NYSE:CNI), with an upside momentum. The trading capacity for the firm moved to ...

Post Analyst
Alexion Pharmaceuticals (ALXN) Downgraded by Zacks Investment Research to Hold  Fairfield Current

Alexion Pharmaceuticals (NASDAQ:ALXN) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note ...

Fairfield Current
Healthcare Stock to Buy: Alexion Pharmaceuticals, Inc. (ALXN)  Wall Street Morning

Technical analysis of Alexion Pharmaceuticals, Inc. (ALXN) stock is the study of technical indicators and past trends. For technical analysis of stock and trends ...

Wall Street Morning
Technicalities drives to Growth: Alexion Pharmaceuticals, Inc. (ALXN), BGC Partners, Inc. (BGCP)  NMSU Nеws

The shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) went down during the trading session by -$6.59 on Friday, trading at $94.63. At the moment, the ...

NMSU Nеws
Silencing the critics: Brookdale Senior Living Inc. (BKD), Alexion Pharmaceuticals, Inc. (ALXN)  FinBulletin

It's been an amazing ride for the share price of Brookdale Senior Living Inc. (NYSE: BKD) since the start of this year, with a year-to-date change of +0.87.

FinBulletin
How to Trade Alexion Pharmaceuticals Inc Momentum After an Earnings Gap Drop  CML News

There is a bearish momentum pattern in Alexion Pharmaceuticals Inc (NSDQ:ALXN) stock 1 trading day after earnings, if and only if the stock showed a large ...

CML News
Alexion Pharmaceuticals, Inc. (ALXN) -22.11% off from 200- SMA  Stocks Gallery

Alexion Pharmaceuticals, Inc. (ALXN) stock price is at a -33.27% downfall to its 52-week high and above 0.29% to a 52-week low. Analysts assigned mean ...

Stocks Gallery
Oppenheimer sees 1H19 risk for smid-cap biotech  Seeking Alpha

Oppenheimer says small- to mid-cap biotech stocks could have more downside risk going into the new year after this quarter's pullback while the historicall.

Seeking Alpha
New Mexico Educational Retirement Board Sold 600 Shares of Alexion Pharmaceuticals, Inc. (ALXN)  BharataPress

New Mexico Educational Retirement Board reduced its stake in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 2.9% during the third quarter, ...

BharataPress
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Stake Boosted by Man Group plc  BharataPress

Man Group plc lifted its holdings in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 54.5% during the third quarter, according to the company in its most recent ...

BharataPress
Alexion Pharmaceuticals (ALXN) vs. Addex Therapeutics (ADDXF) Critical Analysis  BharataPress

Alexion Pharmaceuticals (NASDAQ:ALXN) and Addex Therapeutics (OTCMKTS:ADDXF) are both medical companies, but which is the superior business?

BharataPress
2 Stocks Taking a Gut Shot: Alexion Pharmaceuticals, Inc. (ALXN), TRI Pointe Group, Inc. (TPH)  Post Analyst

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) recent drop took place on significantly more volume which surged nearly 2.51 million contracts on 19-Dec-18 ...

Post Analyst
Alexion Pharmaceuticals (ALXN) PT Set at $156.00 by Credit Suisse Group  Fairfield Current

Alexion Pharmaceuticals (NASDAQ:ALXN) has been assigned a $156.00 target price by analysts at Credit Suisse Group in a research report issued on Sunday, ...

Fairfield Current
Analysts Set Alexion Pharmaceuticals, Inc. (ALXN) Target Price at $163.35  Fairfield Current

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been assigned a consensus rating of “Buy” from the twenty-one ratings firms that are covering the firm, ...

Fairfield Current
Investors Purchase Large Volume of Alexion Pharmaceuticals Put Options (NASDAQ:ALXN)  BharataPress

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was the recipient of unusually large options trading activity on Tuesday. Investors purchased 4,753 put options ...

BharataPress
Alexion Pharmaceuticals, Inc. (ALXN) Stock under Technical Radar  Investing News Update

Alexion Pharmaceuticals, Inc. (ALXN) stock price -0.20% negative depiction highlighted by the trends created around 20 day SMA. The established trader's ...

Investing News Update
Is Momentum Waning From Alexion Pharmaceuticals, Inc. (ALXN), Cirrus Logic, Inc. (CRUS)?  The RNS Daily

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)'s beta now stands at 1.22 and when compared to its 200-day moving average and its 50-day moving average, ...

The RNS Daily
Influential Analyst Rating Changes: Alexion Pharmaceuticals, Inc. (ALXN), Yamana Gold Inc. (AUY)  Analyst Journal

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) tinted gains of +1.24% (+1.35 points) to US$109.96. The volume of 1.54 Million shares climbed down over an ...

Analyst Journal
Intraday News Mover: – Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)  Nyse NewsToday

The Relative Strength Index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to chart the current and historical strength or ...

Nyse NewsToday
Covenant Multifamily Offices Maintains Stake in Apache Com (APA); Alexion Pharmaceuticals (ALXN) Holder At Bancorp Decreased Stake  The FinReviewer

Covenant Multifamily Offices Llc increased its stake in Apache Corp Com (APA) by 24.45% based on its latest 2018Q3 regulatory filing with the SEC. Covenant ...

The FinReviewer
An Estimate Of Target Price: Gulfport Energy Corporation (GPOR), Alexion Pharmaceuticals, Inc. (ALXN)  The RNS Daily

GPOR trading volume has lost -771728 shares compared to readings over the past three months as it recently exchanged 4158272 shares. This means there is ...

The RNS Daily
Trending Stocks Alert: Front Yard Residential Corporation (NYSE:RESI) & Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)  The Newburgh Press

Front Yard Residential Corporation (NYSE:RESI) Front Yard Residential Corporation, operates as a Real Estate Investment Trust (REIT). It acquires ...

The Newburgh Press
Alexion Pharmaceuticals, Inc. (ALXN), Select Energy Services, Inc. (WTTR): If you are looking for the right balance  FinBulletin

Over the last 9-day stretch, shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) were observed to exhibit a Historic Volatility measurement of 43.20%.

FinBulletin
Alexion Pharmaceuticals (ALXN) Stock Unable to Satisfy Bulls For Juicy Yield  Wallstreet Investorplace

Alexion Pharmaceuticals (ALXN) struggling for active trader tendency of a security's returns to respond to swings in the market is vital to know for investment.

Wallstreet Investorplace
Alexion Pharmaceuticals (ALXN) Lowered to “Hold” at BidaskClub  BharataPress

Alexion Pharmaceuticals (NASDAQ:ALXN) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note ...

BharataPress
Be Ready for Active Stock: Alexion Pharmaceuticals (ALXN), Unity Biotechnology (UBX)  News Stays On Track

Alexion Pharmaceuticals (ALXN) Daily Performance: Alexion Pharmaceuticals (ALXN) stock negotiated recent volume of 1467699 shares in recent trading ...

News Stays On Track
Potential Opportunity To Buy or Exit? – Alexion Pharmaceuticals, Inc. (ALXN), ImmunoGen, Inc. (IMGN)  Post Analyst

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is simply too cheap to pass with a price-to-sales ratio of 6.9. The competitors from Major Pharmaceuticals hold ...

Post Analyst
Alexion Pharmaceuticals (ALXN) Ups & Downs Facts After Critical Volatility and volume Analysis  Investing News Update

Alexion Pharmaceuticals (ALXN) stock price jumped 0.88% with the closing value of $110.93 during Thursday trading session. Alexion Pharmaceuticals traded ...

Investing News Update
Bullish or Bearish Territory? Alexion Pharmaceuticals (ALXN)  Connecting Investor

Alexion Pharmaceuticals (ALXN) Stock's Ratio Analysis: The Company was able to keep Return on assets (ROA) at 1.10% in the trailing twelve month.

Connecting Investor
Alexion Pharmaceuticals, Inc. (ALXN) A nticipated to Post Quarterly Sales of $1.06 Billion  BharataPress

Analysts expect Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to post sales of $1.06 billion for the current fiscal quarter, according to Zacks Investment ...

BharataPress
Analysts Estimate: Alexion Pharmaceuticals (ALXN) expected to reach average price target of $164.35  Voice Of Analysts

Alexion Pharmaceuticals (ALXN) stock managed performance 4.84% over the last week and switched with performance of -3.22% throughout past one month ...

Voice Of Analysts
Today’s Picks: Back To School For Alexion Pharmaceuticals, Inc. (ALXN), Avis Budget Group, Inc. (CAR)  GV Times

The price of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) went up by $2.16 now trading at $100.21. Their shares witnessed a 8.26% increase from the ...

GV Times
A Look at the Health of These Stocks Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN)  Richland Standard

After a recent scan, we can see that Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) has a Shareholder Yield of 0.001461 and a Shareholder Yield (Mebane ...

Richland Standard
Seritage Growth Properties (SRG) is at $34.32 per share and Alexion Pharmaceuticals, Inc. (ALXN) is listed at $108.61  Stocks Gallery

In latest trading activity; Seritage Growth Properties (SRG) snatched the consideration from Investors, when its current beneficial picture was seen that is ...

Stocks Gallery
Analyst Research and Recommendations: Exxon Mobil Corporation (XOM), Alexion Pharmaceuticals, Inc. (ALXN)  Analyst Journal

Exxon Mobil Corporation (NYSE:XOM) tinted gains of +2.2% (+1.5 points) to US$69.69. The volume of 17.21 Million shares climbed up over an trading activity of ...

Analyst Journal
Active Stock under Review — Alexion Pharmaceuticals (ALXN)  Stock News Stop

Alexion Pharmaceuticals (ALXN) jumped 0.88% with the finishing price of $110.93 in Thursday Trading Session. The stock price showed -21.20% negative in ...

Stock News Stop
Investor's Alert (Risk Factors' Analysis):: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)  Global Export Lines

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Global Export Lines
Trading summary of Watch List active stock – Alexion Pharmaceuticals, Inc. (ALXN)  Wall Street Morning

On Monday, Dec 24, Alexion Pharmaceuticals, Inc. (ALXN) shares have been seen trading -33.27% off its 52 week- peak value and changed 0.29% from its 52 ...

Wall Street Morning
$1.83 Earnings Per Share Expected for Alexion Pharmaceuticals, Inc. (ALXN) This Quarter  Modern Readers

Wall Street analysts expect Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to post earnings of $1.83 per share for the current fiscal quarter, according to Zacks ...

Modern Readers
Alexion Pharmaceuticals (ALXN) Stock Mix Thrust in Focus on Volatility Analysis  Investing News Update

Simple Moving Average (SMA) Analysis: Alexion Pharmaceuticals (ALXN) stock price -11.51% declining depiction highlighted by the trends created around 20 ...

Investing News Update
2 Stocks Reach Important Points: Ballard Power Systems Inc. (BLDP), Alexion Pharmaceuticals, Inc. (ALXN)  Analyst Journal

Ballard Power Systems Inc. (NASDAQ:BLDP) shares ended at $2.77 with 0.59 mln shares exchanging hands. That puts the market capitalization at $683.66 mln.

Analyst Journal
Are Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN), Sumco Corporation (TSE:3436) Fairly Valued?  Lakeland Observer

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Alexion Pharmaceuticals, Inc.

Lakeland Observer
Don't Miss This Stock: Alexion Pharmaceuticals (ALXN)  News Stays On Track

Alexion Pharmaceuticals (ALXN):. Alexion Pharmaceuticals (ALXN) stock finished at $105.99 and recorded change of -3.23% in Tuesday trading session.

News Stays On Track
Alexion And PTC's Future Seaport HQ Sells For $455M  Bisnow

Skanska's speculative Seaport office tower fetched a hefty sale price.

Bisnow
FirstEnergy Corp. (NYSE:FE), Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) Quant Signals & Earnings Performance Check  Martin Business Telegraph

The EBITDA Yield is a great way to determine a company's profitability. This number is calculated by dividing a company's earnings before.

Martin Business Telegraph
Alexion Pharmaceuticals, Inc. (ALXN) Expected to Post Quarterly Sales of $1.06 Billion  Modern Readers

Equities research analysts predict that Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) will post $1.06 billion in sales for the current quarter, according to Zacks.

Modern Readers
Critical Analysis: Tonix Pharmaceuticals (TNXP) versus Alexion Pharmaceuticals (NASDAQ:ALXN)  Fairfield Current

Alexion Pharmaceuticals (NASDAQ:ALXN) and Tonix Pharmaceuticals (NASDAQ:TNXP) are both medical companies, but which is the superior investment?

Fairfield Current
Financial Analysis: Alexion Pharmaceuticals (NASDAQ:ALXN) vs. Tonix Pharmaceuticals (TNXP)  Modern Readers

Alexion Pharmaceuticals (NASDAQ:ALXN) and Tonix Pharmaceuticals (NASDAQ:TNXP) are both medical companies, but which is the superior investment?

Modern Readers
Comparing Top Moving Stocks Stanley Black & Decker, Inc. (SWK), Alexion Pharmaceuticals, Inc. (ALXN)  StockNewsGazette

The shares of Stanley Black & Decker, Inc. have decreased by more than -29.19% this year alone. The shares recently went up by 2.72% or $3.18 and now ...

StockNewsGazette
Weekly Research Analysts’ Ratings Changes for Alexion Pharmaceuticals (ALXN)  PressOracle

A number of firms have modified their ratings and price targets on shares of Alexion Pharmaceuticals (NASDAQ: ALXN) recently: 12/31/2018 – Alexion ...

PressOracle
Alexion Pharmaceuticals (ALXN) to reach at $164.35 in coming one year period  Voice Of Analysts

Alexion Pharmaceuticals (ALXN) stock managed performance 8.05% over the last week and switched with performance of -15.52% throughout past one month ...

Voice Of Analysts
As Alexion Pharmaceuticals (ALXN) Market Valuation Declined, Montag A & Associates Has Raised Its Stake by $957,571; As Pattern Energy Group (PEGI) Share Value Rose, Carlyle Group LP Has Cut by $86.06 Million Its Position  The FinHeadLines

Carlyle Group Lp decreased its stake in Pattern Energy Group Inc (PEGI) by 88.36% based on its latest 2018Q3 regulatory filing with the SEC. Carlyle Group Lp ...

The FinHeadLines
Alexion Pharmaceuticals (ALXN) Shareholder Ardsley Advisory Partners Has Cut Position by $1.81 Million as Share Value Declined; As Schlumberger LTD (SLB) Market Valuation Declined, Holder Riverpoint Capital Management Cut by $664,680 Its Stake  The Hi New Ulm

Riverpoint Capital Management Llc decreased its stake in Schlumberger Ltd (SLB) by 4.24% based on its latest 2018Q3 regulatory filing with the SEC.

The Hi New Ulm
Alexion Pharmaceuticals (ALXN) Holding Raised by Sound Shore Management Inc; Continental Advisors Raised Position in Brookdale Sr Living (Call) (BKD) by $473,400  The Yomi Blog

Continental Advisors Llc increased its stake in Brookdale Sr Living Inc (Call) (BKD) by 526% based on its latest 2018Q3 regulatory filing with the SEC.

The Yomi Blog
Alexion Pharmaceuticals, Inc. (ALXN) Seeings Quant Profitability at 0.257433  Hawthorn Caller

Traders watching the movements of Alexion Pharmaceuticals, Inc. (ALXN) might be interested in how the quality ratios are stacking up for the shares.

Hawthorn Caller
Analysts Issued Alexion Pharmaceuticals, Inc. (ALXN) Target Price at $163.35  BharataPress

Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have earned a consensus recommendation of “Buy” from the twenty-one ratings firms that are ...

BharataPress
As Alexion Pharmaceuticals (ALXN) Shares Declined, Holder Investec Asset Management LTD Boosted Its Position; Financial Advantage Has Raised Its Position in Realogy Holdings (RLGY) as Market Valuation Declined  The FinExaminer

Investec Asset Management Ltd increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 149.04% based on its latest 2018Q3 regulatory filing with the SEC ...

The FinExaminer
 

Alexion Pharmaceuticals Videos

Alexion Interview
16:12:56
Alexion Interview
Every Dose Matters: George Llado, Alexion Pharmaceuticals | NEXUS '16 Keynote
12:47:39
Every Dose Matters: George Llado, Alexion Pharmaceuticals | NEXUS '16 Keynote
Alexion Career Day NIBRT 2018
12:19:12
Alexion Career Day NIBRT 2018
Alexion Pharmaceuticals, Inc.
14:43:28
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals
13:54:52
Alexion Pharmaceuticals
Working at Alexion Pharmaceuticals - May 2018
20:43:03
Working at Alexion Pharmaceuticals - May 2018
Alexion PNH Complement System video
14:48:07
Alexion PNH Complement System video
Alexion moving out comes as a shock to city officials
22:33:20
Alexion moving out comes as a shock to city officials
Creating Culture Learning Maps: Alexion Pharmaceuticals
13:58:40
Creating Culture Learning Maps: Alexion Pharmaceuticals
ALEXION PHARMACEUTICALS, INC.Company Profile and Tech Intelligence Report, 2018
14:58:49
ALEXION PHARMACEUTICALS, INC.Company Profile and Tech Intelligence Report, 2018
 

Alexion Pharmaceuticals Images

Alexion Pharmaceuticals on the Forbes Global 2000 List
Alexion Pharmaceuticals on the Forbes Global 2000 List
Alexion Pharmaceuticals, Inc. 2018 Q1 - Results - Earnings ...
Alexion Pharmaceuticals, Inc. 2018 Q1 - Results - Earnings ...
Alexion Pharmaceuticals, Inc. - pg.7
Alexion Pharmaceuticals, Inc. - pg.7
Alexion Pharmaceuticals, Inc. 2017 Q1 - Results - Earnings ...
Alexion Pharmaceuticals, Inc. 2017 Q1 - Results - Earnings ...
Alexion Pharmaceuticals, Inc. 2016 Q3 - Results - Earnings ...
Alexion Pharmaceuticals, Inc. 2016 Q3 - Results - Earnings ...
The Zacks Analyst Blog Highlights: Gilead Sciences ...
The Zacks Analyst Blog Highlights: Gilead Sciences ...
Alexion Pharmaceuticals Challenges Ottawa's Ability To ...
Alexion Pharmaceuticals Challenges Ottawa's Ability To ...
'Orphan drug' maker sues Canada for trying to lower cost ...
'Orphan drug' maker sues Canada for trying to lower cost ...
17 Best ideas about Paroxysmal Nocturnal Hemoglobinuria on ...
17 Best ideas about Paroxysmal Nocturnal Hemoglobinuria on ...
LNP Delivery Platform | Our Science | Arbutus Biopharma
LNP Delivery Platform | Our Science | Arbutus Biopharma
 

Alexion Pharmaceuticals WebSites